Reading Comprehension Impairment in Children With Neurofibromatosis Type 1 (NF1): The Need of Multimodal Assessment of Attention.


Journal

Journal of child neurology
ISSN: 1708-8283
Titre abrégé: J Child Neurol
Pays: United States
ID NLM: 8606714

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 29 1 2021
medline: 13 1 2022
entrez: 28 1 2021
Statut: ppublish

Résumé

Attention span, which has been shown to have an impact on reading quality in many other conditions, is one of the main cognitive disorders of neurofibromatosis type 1 (NF1). The aim of this work is to observe the impact of attention on reading comprehension, in NF1 and non-NF1 children. A multicenter, cross-sectional study was conducted on 150 children (8-12 years old) with or without NF1 (75 NF1 vs 75 non-NF1; 72 female, 78 male), matched for age, sex, handedness, and reading level, thus forming a continuum from good to poor readers in both NF1 and non-NF1 groups. Children with intellectual deficiency or neurologic or psychiatric disorder were excluded. Attentional skills were assessed by combining a parent questionnaire (Child Behavior CheckList) and a performance-based assessment (Conner's Continuous Performance Test-Second Edition). Reading comprehension was assessed through a standardized reading comprehension test (ORLEC Lobrot). The performance-based attention scores were associated with text and sentence comprehension ability (

Identifiants

pubmed: 33507832
doi: 10.1177/0883073820981270
doi:

Banques de données

ClinicalTrials.gov
['NCT02397967']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

625-634

Auteurs

Maëlle Biotteau (M)

ToNIC, Toulouse NeuroImaging Center, University of Toulouse, 27102Inserm, UPS, France.
Children's Hospital, Toulouse-Purpan University Hospital, Toulouse, France.

Elodie Tournay (E)

Epidemiology Department, Toulouse University Hospital, Toulouse, France.

Eloise Baudou (E)

ToNIC, Toulouse NeuroImaging Center, University of Toulouse, 27102Inserm, UPS, France.
Children's Hospital, Toulouse-Purpan University Hospital, Toulouse, France.

Sandrine Destarac (S)

Pediatric Clinical Research Unit, Toulouse Clinical Investigation Center, Children's Hospital, Purpan University Hospital, Inserm U1436, Toulouse, France.

Stéphanie Iannuzzi (S)

Children's Hospital, Toulouse-Purpan University Hospital, Toulouse, France.

Nathalie Faure-Marie (N)

Children's Hospital, Toulouse-Purpan University Hospital, Toulouse, France.

Pierre Castelnau (P)

Pediatric Neurology, Clocheville Children's Hospital, Tours University Hospital, Tours, France.
UMR 1253, iBrain, University fo Tours, 27102Inserm, Tours, France.
School of Medicine, University of Tours Francois Rabelais, Tours, France.

Elisabeth Schweitzer (E)

Pediatric Neurology, Clocheville Children's Hospital, Tours University Hospital, Tours, France.

Diana Rodriguez (D)

Sorbonne University, APHP.SU, Department of Neuropediatry & Reference Center for Neurogenetics Disabilities, Armand Trousseau University Hospital, Paris, France.
Inserm U1141, FHU I2-D2, Paris, France.

Isabelle Kemlin (I)

Sorbonne University, APHP.SU, Department of Neuropediatry & Reference Center for Neurogenetics Disabilities, Armand Trousseau University Hospital, Paris, France.

Nathalie Dorison (N)

Sorbonne University, APHP.SU, Department of Neuropediatry & Reference Center for Neurogenetics Disabilities, Armand Trousseau University Hospital, Paris, France.

François Rivier (F)

Department of Pediatric Neurology, Montpellier University Hospital, PhyMedExp, University of Montpellier, Inserm, CNRS, Montpellier, France.

Maryline Carneiro (M)

Department of Pediatric Neurology & Reference Center for Language Disabilities, Montpellier University Hospital, France.

Elodie Preclaire (E)

Department of Pediatric Neurology & Reference Center for Language Disabilities, Montpellier University Hospital, France.

Sebastien Barbarot (S)

Departement of Dermatology, Nantes University Hospital, Nantes, France.

Valérie Lauwers-Cancès (V)

Epidemiology Department, Toulouse University Hospital, Toulouse, France.

Yves Chaix (Y)

ToNIC, Toulouse NeuroImaging Center, University of Toulouse, 27102Inserm, UPS, France.
Children's Hospital, Toulouse-Purpan University Hospital, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH